Education Sessions
Competing in the Global Marketplace (302)
| 27 October 13.30-17.00 | Track: Manufacturing Operations |
ISPE CEUs: 0.2
(PDF Current as of 2 October 2008)
Challenge the current state of the pharmaceutical industry with these provocative questions. Join in this stimulating discussion as we tackle these questions with a panel of leaders.
- Is risk-adversity suicide in the face of competition? Change is essential, yet numerous companies avoid change because it comes with risk.
- Why build more and more elaborate facilities using more and more energy?
- Why use equipment and processes a baker in the 1900s would recognize?
- Why believe the regulator is the enemy?
- Why do we still find silos when quality, regulatory, toxicology, validation, and others rarely talk to each other?
The world cannot be changed in two and one-half hours, but the intention is to provoke thought, encourage discussion, and promote productive change.
How You Will Benefit
At the end of this session, participants will be able to:
- Understand the issues that delegates raise as most challenging
- Become open to possible new solutions
- Create change or at least start the discussion
Who Should Attend
Senior management and decision makers
ISPE Communities of Practice (COPs)
All COPs
Session Leader
- Julian Wilkins, Vice President, PharmaConsult US Inc, USA
Session Speakers
- Ali Afnan, Senior Staff Fellow, FDA/CDER, USA
- John Fielding, Senior Director, Genentech, USA
- Hans Rosling, Prof. of Int'l Health, Karolinska Institute, Sweden
- Russ Somma, President, SommaTech, LLC, USA